“Uncovering the Truth: Did Intellia Therapeutics Inc Mislead Investors? A Closer Look at Shareholder Rights”
Welcome to our Blog Post on the Investigation of Intellia Therapeutics, Inc. New York City, NY / ACCESS Newswire / January 24, 2025 Levi & Korsinsky notifies investors that it has commenced an investigation of Intellia Therapeutics, Inc. (“Intellia Therapeutics, Inc.”) (NASDAQ:NTLA) concerning possible violations of federal securities laws. Intellia issued a press release on…